David G Ichikawa - Net Worth and Insider Trading

David G Ichikawa Net Worth

The estimated net worth of David G Ichikawa is at least $0 dollars as of 2024-11-13. David G Ichikawa is the Senior VP, Bus. Dev. of Sangamo Therapeutics Inc and owns about 0 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $0. Details can be seen in David G Ichikawa's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David G Ichikawa has not made any transactions after 2011-07-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David G Ichikawa

To

David G Ichikawa Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David G Ichikawa owns 1 companies in total, including Sangamo Therapeutics Inc (SGMO) .

Click here to see the complete history of David G Ichikawa’s form 4 insider trades.

Insider Ownership Summary of David G Ichikawa

Ticker Comapny Transaction Date Type of Owner
SGMO Sangamo Therapeutics Inc 2011-07-07 Senior VP & Bus. Dev.

David G Ichikawa Latest Holdings Summary

David G Ichikawa currently owns a total of 1 stock. David G Ichikawa owns 0 shares of Sangamo Therapeutics Inc (SGMO) as of July 7, 2011, with a value of $0.

Latest Holdings of David G Ichikawa

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGMO Sangamo Therapeutics Inc 2011-07-07 0 2.71 0

Holding Weightings of David G Ichikawa


David G Ichikawa Form 4 Trading Tracker

According to the SEC Form 4 filings, David G Ichikawa has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 4,000 shares on July 7, 2011, which brought David G Ichikawa around $25,880.

Insider Trading History of David G Ichikawa

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David G Ichikawa Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David G Ichikawa Ownership Network

Ownership Network List of David G Ichikawa

No Data

Ownership Network Relation of David G Ichikawa

Insider Network Chart

David G Ichikawa Owned Company Details

What does Sangamo Therapeutics Inc do?

Who are the key executives at Sangamo Therapeutics Inc?

David G Ichikawa is the Senior VP & Bus. Dev. of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .

Sangamo Therapeutics Inc (SGMO) Insider Trades Summary

Over the past 18 months, David G Ichikawa made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.

Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sangamo Therapeutics Inc Insider Transactions

No Available Data

David G Ichikawa Mailing Address

Above is the net worth, insider trading, and ownership report for David G Ichikawa. You might contact David G Ichikawa via mailing address: C/o Sangamo Biosciences, Inc., 501 Canal Blvd Suite A-100, Richmond Ca 94804.